Gerald Gartlehner

Gerald Gartlehner

Top Cited Scholar 2025
Auto-generated profile, based on publicly available information

Gerald Gartlehner

Cochrane Austria, Department for Evidence-based Medicine and Evaluation, University for Continuing Education Krems (Danube University Krems), Krems, Austria; and RTI International, Research Triangle Park, North Carolina (G.G.).

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2005 in Obstetrics & Gynecology
Verified
Journal Article
Closed access
NGNorma I. Gavin
Norma I. Gavin
BGBradley N. Gaynes
Bradley N. Gaynes
KLKathleen N. Lohr
Kathleen N. Lohr
SMSamantha Meltzer-Brody
Samantha Meltzer-Brody
GGGerald Gartlehner
Gerald Gartlehner
TSTammeka Swinson
Tammeka Swinson
We systematically review evidence on the prevalence and incidence of perinatal depression and compare these rates with those of depression in women at non-childbearing times. We searched MEDLINE, CINAHL, PsycINFO, and Sociofile for English-language articles published from 1980 through March 2004, conducted hand searches of bibliographies, and consulted with experts. We included cross-sectional, cohort, and case-control studies from developed countries that assessed women for depression during pregnancy or the first year postpartum with a structured clinical interview. Of the 109 articles reviewed, 28 met our inclusion criteria. For major and minor depression (major depression alone), the combined point prevalence estimates from meta-analyses ranged from 6.5% to 12.9% (1.0-5.6%) at different trimesters of pregnancy and months in the first postpartum year. The combined period prevalence shows that as many as 19.2% (7.1%) of women have a depressive episode (major depressive episode) during the first 3 months postpartum; most of these episodes have onset following delivery. All estimates have wide 95% confidence intervals, showing significant uncertainty in their true levels. No conclusions could be made regarding the relative incidence of depression among pregnant and postpartum women compared with women at non-childbearing times. To better delineate periods of peak prevalence and incidence for perinatal depression and identify high risk subpopulations, we need studies with larger and more representative samples.

1 July 2019 in Journal of Clinical Epidemiology
Verified
Journal Article
Open access
HSHolger J. Schünemann
Holger J. Schünemann
CCCarlos Cuello
Carlos Cuello
EAElie Akl
Elie Akl
RMReem A. Mustafa
Reem A. Mustafa
JMJörg J. Meerpohl
Jörg J. Meerpohl
Gordon GuyattGordon Guyatt
Gordon Guyatt
To provide guidance on how systematic review authors, guideline developers, and health technology assessment practitioners should approach the use of the risk of bias in nonrandomized studies of interventions (ROBINS-I) tool as a part of GRADE's certainty rating process. The study design and setting comprised iterative discussions, testing in systematic reviews, and presentation at GRADE working group meetings with feedback from the GRADE working group. We describe where to start the initial assessment of a body of evidence with the use of ROBINS-I and where one would anticipate the final rating would end up. The GRADE accounted for issues that mitigate concerns about confounding and selection bias by introducing the upgrading domains: large effects, dose-effect relations, and when plausible residual confounders or other biases increase certainty. They will need to be considered in an assessment of a body of evidence when using ROBINS-I. The use of ROBINS-I in GRADE assessments may allow for a better comparison of evidence from randomized controlled trials (RCTs) and nonrandomized studies (NRSs) because they are placed on a common metric for risk of bias. Challenges remain, including appropriate presentation of evidence from RCTs and NRSs for decision-making and how to optimally integrate RCTs and NRSs in an evidence assessment.

1 July 2017 in Journal of Clinical Epidemiology
Verified
Journal Article
Open access
MHMonica Hultcrantz
Monica Hultcrantz
DRDavid Rind
David Rind
EAElie A. Akl
Elie A. Akl
STShaun Treweek
Shaun Treweek
RMReem A. Mustafa
Reem A. Mustafa
GGGordon Guyatt
Gordon Guyatt
To clarify the grading of recommendations assessment, development and evaluation (GRADE) definition of certainty of evidence and suggest possible approaches to rating certainty of the evidence for systematic reviews, health technology assessments, and guidelines. This work was carried out by a project group within the GRADE Working Group, through brainstorming and iterative refinement of ideas, using input from workshops, presentations, and discussions at GRADE Working Group meetings to produce this document, which constitutes official GRADE guidance. Certainty of evidence is best considered as the certainty that a true effect lies on one side of a specified threshold or within a chosen range. We define possible approaches for choosing threshold or range. For guidelines, what we call a fully contextualized approach requires simultaneously considering all critical outcomes and their relative value. Less-contextualized approaches, more appropriate for systematic reviews and health technology assessments, include using specified ranges of magnitude of effect, for example, ranges of what we might consider no effect, trivial, small, moderate, or large effects. It is desirable for systematic review authors, guideline panelists, and health technology assessors to specify the threshold or ranges they are using when rating the certainty in evidence.

1 November 2011 in Journal of Clinical Epidemiology
Verified
Journal Article
Closed access
RFRongwei Fu
Rongwei Fu
GGGerald Gartlehner
Gerald Gartlehner
MGMark Grant
Mark Grant
TSTatyana Shamliyan
Tatyana Shamliyan
ASArt Sedrakyan
Art Sedrakyan
TTThomas A. Trikalinos
Thomas A. Trikalinos

22 October 2019 in Depression and Anxiety
Verified
Journal Article
Closed access
PDF file
BGBradley N. Gaynes
Bradley N. Gaynes
LLLinda Lux
Linda Lux
GGGerald Gartlehner
Gerald Gartlehner
GAGary Asher
Gary Asher
VFValerie Forman‐Hoffman
Valerie Forman‐Hoffman
KLKathleen N. Lohr
Kathleen N. Lohr

1 February 2020 in Journal of Clinical Epidemiology
Verified
Journal Article
Closed access
BNB. Nussbaumer-Streit
B. Nussbaumer-Streit
IKI. Klerings
I. Klerings
ADA.I. Dobrescu
A.I. Dobrescu
EPE. Persad
E. Persad
ASA. Stevens
A. Stevens
GGG. Gartlehner
G. Gartlehner